<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="truncate">
            <roleset id="Truncate.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="cause&#x09;&#x09;&#x09;// mutation //&#x0A;" />
                    <role n="1" descr="entity getting shorter &#x09;// gene products //&#x0A;" />
                    <role n="2" descr="entity removed&#x09;&#x09;// domains, exon, intron //&#x0A;" />
                    <role n="3" descr='break point &#x09;&#x09;/* related to prepositional phrase such as &quot;at&quot;, &quot;prior to&quot; */&#x0A;' />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Almost all A0 mutations (TSC1) are found to truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Almost all A0 mutations (TSC1) are found to truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Almost all EMCV mutations have truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Almost all TSC1 mutations have truncated the protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>EMCV frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">EMCV</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and protein product that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and the protein that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>For the generation of this protein, PVR can be truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>For the generation of this protein, PVR is able to be truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>For the generation of this protein, PVR is able to be truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>For the generation of this protein, PVR is likely to be truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>For the generation of this protein, PVR is truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>For the generation of this protein, PVR is truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>For the generation of this protein, PVR may have been truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>For the generation of this protein, PVR may have been truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>For the generation of this protein, PVR was truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>For the generation of this protein, PVR will be truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>For the generation of this protein, PVR will be truncated before PP reason (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>For the generation of this protein, it is observed that PVR is truncated before PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>For the generation of this protein, it is observed that PVR is truncated before PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>For the generation of this protein, the PVR was truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP reason</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>It has been shown that Merchshift SOX9 truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>It has been shown that SOX9 shift motion frame truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>It has been shown that SOX9 shift of frame truncates its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>It has been shown that frameshift SOX9 mutations truncates both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>It has been shown that frameshift SOX9 mutations truncates its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>It has been shown that frameshift SOX9 mutations truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>It has been shown that frameshift SOX9 mutations truncates their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>It has been shown that frameshift SOX9 truncates its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>It has been shown that frameshift SOX9 truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>It has been shown that merchshift SOX9 mutations truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>It has been shown that of SOX9 truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>It has been shown that of SOX9 truncates the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>It has been shown that soX9 shift frame changes truncates its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>It has been shown that soX9 shift frame changes truncates six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>It has been shown that the Merchshift SOX9 mutations truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>It has been shown that the Merchshift SOX9 truncates to the six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>It has been shown that the SOX9 shift frame changes truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>It has been shown that the SOX9 shift motion frame truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>It has been shown that the SOX9 shift motion frame truncates to the six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>It has been shown that the SOX9 shifts of frame change truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>It has been shown that the frameshift SOX9 mutations truncates to the both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>It has been shown that the frameshift SOX9 mutations truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>It has been shown that the frameshift SOX9 mutations truncates to the their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>It has been shown that the frameshift SOX9 truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>It has been shown that the merchshift SOX9 mutations truncates to the six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>It has been shown that the of SOX9 truncates to the six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>It has been shown that the of SOX9 truncates to the the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>It has been shown that the soX9 shift frame changes truncates to the its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>It has been shown that the soX9 shift frame changes truncates to the six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>It is observed that Merchshift SOX9 actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>It is observed that Merchshift SOX9 actually truncates to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>It is observed that Merchshift SOX9 mutations actually truncates to its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>It is observed that Merchshift SOX9 mutations truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>It is observed that Merchshift SOX9 truncates six activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>It is observed that SOX9 shift frame changes actually truncates to its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>It is observed that SOX9 shift frame changes actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>It is observed that SOX9 shift frame changes truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>It is observed that SOX9 shift motion frame actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>It is observed that SOX9 shift motion frame actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>It is observed that SOX9 shift motion frame truncates six activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>It is observed that SOX9 shift of frame actually truncates to its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>It is observed that SOX9 shift of frame actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>It is observed that SOX9 shift of frame truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>It is observed that SOX9 shifts of frame change actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>It is observed that SOX9 shifts of frame change truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>It is observed that frameshift SOX9 actually truncates to its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>It is observed that frameshift SOX9 actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>It is observed that frameshift SOX9 actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>It is observed that frameshift SOX9 mutations actually truncates to their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>It is observed that frameshift SOX9 mutations truncates both activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>It is observed that frameshift SOX9 mutations truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>It is observed that frameshift SOX9 mutations truncates their two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>It is observed that frameshift SOX9 truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>It is observed that merchshift SOX9 mutations actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>It is observed that merchshift SOX9 mutations actually truncates to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>It is observed that merchshift SOX9 mutations truncates six activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>It is observed that of SOX9 actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>It is observed that of SOX9 actually truncates to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>It is observed that of SOX9 actually truncates to the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>It is observed that of SOX9 actually truncates to the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>It is observed that of SOX9 truncates six activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>It is observed that of SOX9 truncates the two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>It is observed that soX9 shift frame changes actually truncates to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>It is observed that soX9 shift frame changes actually truncates to six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>It is observed that soX9 shift frame changes actually truncates to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>It is observed that soX9 shift frame changes truncates its two activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>It is observed that soX9 shift frame changes truncates six activation domains, while all the counter-sense mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>It is observed that the Merchshift SOX9 mutations truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>It is observed that the Merchshift SOX9 truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>It is observed that the SOX9 shift frame changes truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>It is observed that the SOX9 shift motion frame truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>It is observed that the SOX9 shift of frame truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>It is observed that the SOX9 shifts of frame change truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>It is observed that the frameshift SOX9 mutations truncates the both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>It is observed that the frameshift SOX9 mutations truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>It is observed that the frameshift SOX9 mutations truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>It is observed that the frameshift SOX9 mutations truncates the their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>It is observed that the frameshift SOX9 truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>It is observed that the merchshift SOX9 mutations truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>It is observed that the of SOX9 truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>It is observed that the of SOX9 truncates the the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>It is observed that the soX9 shift frame changes truncates the its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>It is observed that the soX9 shift frame changes truncates the six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Merchshift SOX9 actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Merchshift SOX9 actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Merchshift SOX9 can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Merchshift SOX9 can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Merchshift SOX9 frame change, as shown in our data, is observed to truncate six activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Merchshift SOX9 frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Merchshift SOX9 frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Merchshift SOX9 has been shown to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Merchshift SOX9 has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Merchshift SOX9 has the ability to actually truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Merchshift SOX9 has the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Merchshift SOX9 has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Merchshift SOX9 have the probability of actually truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Merchshift SOX9 have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Merchshift SOX9 have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Merchshift SOX9 is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Merchshift SOX9 is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Merchshift SOX9 is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Merchshift SOX9 is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Merchshift SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Merchshift SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Merchshift SOX9 is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Merchshift SOX9 is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Merchshift SOX9 may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Merchshift SOX9 may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Merchshift SOX9 may have truncated six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Merchshift SOX9 may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Merchshift SOX9 mutations actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Merchshift SOX9 mutations can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Merchshift SOX9 mutations frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Merchshift SOX9 mutations frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Merchshift SOX9 mutations frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Merchshift SOX9 mutations has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Merchshift SOX9 mutations has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Merchshift SOX9 mutations is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Merchshift SOX9 mutations is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Merchshift SOX9 mutations is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Merchshift SOX9 mutations may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Merchshift SOX9 mutations may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Merchshift SOX9 mutations may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Merchshift SOX9 mutations may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Merchshift SOX9 mutations will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Merchshift SOX9 mutations, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Merchshift SOX9 mutations, as our data show, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Merchshift SOX9 mutations, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Merchshift SOX9 mutations, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Merchshift SOX9 mutations, as our data show, may have truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Merchshift SOX9 mutations, as our data show, truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Merchshift SOX9 mutations, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Merchshift SOX9 mutations, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Merchshift SOX9 mutations, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Merchshift SOX9 mutations, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Merchshift SOX9 mutations, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Merchshift SOX9 mutations, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Merchshift SOX9 mutations, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Merchshift SOX9 truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Merchshift SOX9 truncated six activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Merchshift SOX9 will actually truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Merchshift SOX9 will truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Merchshift SOX9 will truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Merchshift SOX9, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Merchshift SOX9, as our data show, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Merchshift SOX9, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Merchshift SOX9, as our data show, is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Merchshift SOX9, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Merchshift SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Merchshift SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Merchshift SOX9, as our data show, will truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Merchshift SOX9, as our data, are susceptible to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Merchshift SOX9, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Merchshift SOX9, as our data, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Merchshift SOX9, as our data, may truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Merchshift SOX9, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>Merchshift SOX9, as shown by our data, are able to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>Merchshift SOX9, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>Merchshift SOX9, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>Merchshift SOX9, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>Merchshift SOX9, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>Merchshift SOX9, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>Merchshift SOX9, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>Merchshift SOX9, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Merchshift SOX9, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Merchshift SOX9, as shown by our data, is observed to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Merchshift SOX9, as shown by our data, is observed to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Merchshift SOX9, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Merchshift SOX9, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Merchshift SOX9, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Merchshift SOX9, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">Merchshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Most of the alterations found were the truncation a protein that expresses bacteria through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Practically all A0 mutations (TSC1) are able to truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Practically all A0 mutations (TSC1) can truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Practically all A0 mutations (TSC1) can truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Practically all A0 mutations (TSC1) may have truncated a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Practically all A0 mutations (TSC1) truncated a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Practically all A0 mutations (TSC1) truncated the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate a protein that expresses bacteria.</text>
                    <arg n="1">a protein that expresses bacteria</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Practically all A0 mutations (TSC1) will truncate the protein.</text>
                    <arg n="1">the protein</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Practically all EMCV mutations are able to dramatically truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Practically all EMCV mutations are able to dramatically truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Practically all EMCV mutations are able to truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Practically all EMCV mutations can dramatically truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Practically all EMCV mutations can dramatically truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Practically all EMCV mutations can truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Practically all EMCV mutations can truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Practically all EMCV mutations dramatically truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Practically all EMCV mutations dramatically truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Practically all EMCV mutations have been predicted to dramatically truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Practically all EMCV mutations have been predicted to dramatically truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Practically all EMCV mutations have been predicted to truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Practically all EMCV mutations have dramatically truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Practically all EMCV mutations have the ability to dramatically truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Practically all EMCV mutations have the ability to dramatically truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Practically all EMCV mutations have the ability to truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>Practically all EMCV mutations have the ability to truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>Practically all EMCV mutations have truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>Practically all EMCV mutations have truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>Practically all EMCV mutations may have dramatically truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>Practically all EMCV mutations may have dramatically truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>Practically all EMCV mutations may have truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>Practically all EMCV mutations may have truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>Practically all EMCV mutations truncated poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>Practically all EMCV mutations truncated sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>Practically all EMCV mutations were predicted to truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>Practically all EMCV mutations were predicted to truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>Practically all EMCV mutations will dramatically truncate poly(C) sectors.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>Practically all EMCV mutations will dramatically truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>Practically all TSC1 mutations are able to dramatically truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>Practically all TSC1 mutations can dramatically truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>Practically all TSC1 mutations can truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>Practically all TSC1 mutations dramatically truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>Practically all TSC1 mutations have been predicted to dramatically truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>Practically all TSC1 mutations have dramatically truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>Practically all TSC1 mutations have the ability to dramatically truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>Practically all TSC1 mutations have the ability to truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>Practically all TSC1 mutations have truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>Practically all TSC1 mutations may have dramatically truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>Practically all TSC1 mutations may have truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>Practically all TSC1 mutations truncated protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>Practically all TSC1 mutations were predicted to truncate the protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>Practically all TSC1 mutations will dramatically truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>Practically all mutations EMCV will truncate sectors Poly(C).</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>Practically all mutations TSC1 will truncate protein product.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>Previous studies using the Encephalomyocarditis Virus Type EMCV and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>Previous studies using the Encephalomyocarditis Virus Type EMCV and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>Previous studies using the Encephalomyocarditis Virus Type TSC1 and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>Previous studies using the Encephalomyocarditis Virus Type of SOX9 and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>Previous studies using the Encephalomyocarditis Virus Type of SOX9 and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>Previous studies using the Encephalomyocarditis Virus Type of SOX9 and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>Previous studies using the Encephalomyocarditis Virus Type of SOX9 and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>Previous studies using the Encephalomyocarditis Virus type EMCV and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>Previous studies using the Encephalomyocarditis Virus type TSC1 and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>Previous studies using the Encephalomyocarditis Virus type TSC1 and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>Previous studies using the Encephalomyocarditis Virus type of SOX9 and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>Previous studies using the Encephalomyocarditis virus type EMCV and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace sectors Poly(C) produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">sectors Poly(C)</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>Previous studies using the Encephalomyocarditis virus type TSC1 and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace the protein product produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>Previous studies using the encephalomiocarditis virus type EMCV and Mengo virus, and variants of these viruses, have been shown to replace or truncate poly(C) sectors to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">EMCV</arg>
                    <arg n="1">poly(C) sectors</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>Previous studies using the encephalomiocarditis virus type TSC1 and Mengo virus, and variants of these viruses, have been shown to replace or truncate protein product to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>Previous studies using the encephalomiocarditis virus type TSC1 and Mengo virus, and variants of these viruses, have been shown to replace or truncate the protein product to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">TSC1</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>Previous studies using the encephalomiocarditis virus type of SOX9 and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>Previous studies using the encephalomiocarditis virus type of SOX9 and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>Previous studies using the encephalomiocarditis virus type of SOX9 and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>Previous studies using the encephalomiocarditis virus type of SOX9 and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>Previous studies using the encephalomiocarditis virus type of SOX9 and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">of SOX9</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>SOX9 shift frame changes actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>SOX9 shift frame changes actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>SOX9 shift frame changes can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>SOX9 shift frame changes can truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>SOX9 shift frame changes can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>SOX9 shift frame changes frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>SOX9 shift frame changes frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>SOX9 shift frame changes frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>SOX9 shift frame changes has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>SOX9 shift frame changes has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>SOX9 shift frame changes has the ability to actually truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>SOX9 shift frame changes has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>SOX9 shift frame changes has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>SOX9 shift frame changes have the probability of actually truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>SOX9 shift frame changes have the probability of truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>SOX9 shift frame changes have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>SOX9 shift frame changes is able to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>SOX9 shift frame changes is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>SOX9 shift frame changes is likely to actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>SOX9 shift frame changes is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>SOX9 shift frame changes is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>SOX9 shift frame changes is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>SOX9 shift frame changes is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>SOX9 shift frame changes may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>SOX9 shift frame changes may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>SOX9 shift frame changes may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>SOX9 shift frame changes may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>SOX9 shift frame changes truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>SOX9 shift frame changes truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>SOX9 shift frame changes will truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>SOX9 shift frame changes will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>SOX9 shift frame changes, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>SOX9 shift frame changes, as our data show, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>SOX9 shift frame changes, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>SOX9 shift frame changes, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>SOX9 shift frame changes, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>SOX9 shift frame changes, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>SOX9 shift frame changes, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>SOX9 shift frame changes, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>SOX9 shift frame changes, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>SOX9 shift frame changes, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>SOX9 shift frame changes, as shown by our data, actually truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>SOX9 shift frame changes, as shown by our data, are able to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>SOX9 shift frame changes, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>SOX9 shift frame changes, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>SOX9 shift frame changes, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>SOX9 shift frame changes, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>SOX9 shift frame changes, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>SOX9 shift frame changes, as shown by our data, has shown to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>SOX9 shift frame changes, as shown by our data, have the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>SOX9 shift frame changes, as shown by our data, have the probability of actually truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>SOX9 shift frame changes, as shown by our data, have the probability of truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>SOX9 shift frame changes, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>SOX9 shift frame changes, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>SOX9 shift frame changes, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>SOX9 shift frame changes, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>SOX9 shift frame changes, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>SOX9 shift frame changes, as shown by our data, will truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>SOX9 shift frame changes, such as our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>SOX9 shift motion frame actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>SOX9 shift motion frame actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>SOX9 shift motion frame actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>SOX9 shift motion frame actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>SOX9 shift motion frame can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>SOX9 shift motion frame can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>SOX9 shift motion frame can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>SOX9 shift motion frame can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>SOX9 shift motion frame frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>SOX9 shift motion frame frame change, as shown in our data, is observed to truncate six activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>SOX9 shift motion frame frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>SOX9 shift motion frame frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>SOX9 shift motion frame frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>SOX9 shift motion frame frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>SOX9 shift motion frame has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>SOX9 shift motion frame has been shown to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>SOX9 shift motion frame has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>SOX9 shift motion frame has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>SOX9 shift motion frame has the ability to actually truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>SOX9 shift motion frame has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>SOX9 shift motion frame has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>SOX9 shift motion frame has the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>SOX9 shift motion frame has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>SOX9 shift motion frame have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>SOX9 shift motion frame have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>SOX9 shift motion frame is able to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>SOX9 shift motion frame is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>SOX9 shift motion frame is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>SOX9 shift motion frame is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>SOX9 shift motion frame is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>SOX9 shift motion frame is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>SOX9 shift motion frame is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>SOX9 shift motion frame is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>SOX9 shift motion frame is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>SOX9 shift motion frame is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>SOX9 shift motion frame is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>SOX9 shift motion frame is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>SOX9 shift motion frame may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>SOX9 shift motion frame may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>SOX9 shift motion frame may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>SOX9 shift motion frame may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>SOX9 shift motion frame may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>SOX9 shift motion frame may have truncated six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>SOX9 shift motion frame may have truncated six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>SOX9 shift motion frame may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>SOX9 shift motion frame may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>SOX9 shift motion frame may truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>SOX9 shift motion frame may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>SOX9 shift motion frame truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>SOX9 shift motion frame truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>SOX9 shift motion frame truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>SOX9 shift motion frame truncated six activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>SOX9 shift motion frame will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>SOX9 shift motion frame will truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>SOX9 shift motion frame will truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>SOX9 shift motion frame, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>SOX9 shift motion frame, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>SOX9 shift motion frame, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>SOX9 shift motion frame, as our data show, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>SOX9 shift motion frame, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>SOX9 shift motion frame, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>SOX9 shift motion frame, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>SOX9 shift motion frame, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>SOX9 shift motion frame, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>SOX9 shift motion frame, as our data show, is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>SOX9 shift motion frame, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>SOX9 shift motion frame, as our data show, it is likely that six activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>SOX9 shift motion frame, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>SOX9 shift motion frame, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>SOX9 shift motion frame, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>SOX9 shift motion frame, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>SOX9 shift motion frame, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>SOX9 shift motion frame, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>SOX9 shift motion frame, as our data, are susceptible to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>SOX9 shift motion frame, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>SOX9 shift motion frame, as our data, may truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>SOX9 shift motion frame, as shown by our data, actually truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>SOX9 shift motion frame, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>SOX9 shift motion frame, as shown by our data, are able to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>SOX9 shift motion frame, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>SOX9 shift motion frame, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>SOX9 shift motion frame, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>SOX9 shift motion frame, as shown by our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>SOX9 shift motion frame, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>SOX9 shift motion frame, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>SOX9 shift motion frame, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>SOX9 shift motion frame, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>SOX9 shift motion frame, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>SOX9 shift motion frame, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>SOX9 shift motion frame, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>SOX9 shift motion frame, as shown by our data, have the probability of actually truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>SOX9 shift motion frame, as shown by our data, have the probability of truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>SOX9 shift motion frame, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>SOX9 shift motion frame, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>SOX9 shift motion frame, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>SOX9 shift motion frame, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>SOX9 shift motion frame, as shown by our data, is observed to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>SOX9 shift motion frame, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>SOX9 shift motion frame, as shown by our data, is observed to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>SOX9 shift motion frame, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>SOX9 shift motion frame, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>SOX9 shift motion frame, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>SOX9 shift motion frame, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>SOX9 shift motion frame, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>SOX9 shift motion frame, as shown by our data, will actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>SOX9 shift motion frame, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>SOX9 shift motion frame, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>SOX9 shift motion frame, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>SOX9 shift motion frame, such as our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift motion frame</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>SOX9 shift of frame actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>SOX9 shift of frame actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>SOX9 shift of frame can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>SOX9 shift of frame can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>SOX9 shift of frame frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>SOX9 shift of frame frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>SOX9 shift of frame frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>SOX9 shift of frame has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>SOX9 shift of frame has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>SOX9 shift of frame has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>SOX9 shift of frame have the probability of truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>SOX9 shift of frame is able to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>SOX9 shift of frame is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>SOX9 shift of frame is likely to actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>SOX9 shift of frame is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>SOX9 shift of frame is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>SOX9 shift of frame is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>SOX9 shift of frame is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>SOX9 shift of frame is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>SOX9 shift of frame may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>SOX9 shift of frame may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>SOX9 shift of frame may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>SOX9 shift of frame truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>SOX9 shift of frame truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>SOX9 shift of frame will actually truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>SOX9 shift of frame will truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>SOX9 shift of frame will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>SOX9 shift of frame, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>SOX9 shift of frame, as our data show, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>SOX9 shift of frame, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>SOX9 shift of frame, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>SOX9 shift of frame, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>SOX9 shift of frame, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>SOX9 shift of frame, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>SOX9 shift of frame, as our data show, may have truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>SOX9 shift of frame, as our data show, truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>SOX9 shift of frame, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>SOX9 shift of frame, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>SOX9 shift of frame, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>SOX9 shift of frame, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>SOX9 shift of frame, as shown by our data, actually truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>SOX9 shift of frame, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>SOX9 shift of frame, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>SOX9 shift of frame, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>SOX9 shift of frame, as shown by our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>SOX9 shift of frame, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>SOX9 shift of frame, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>SOX9 shift of frame, as shown by our data, have the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>SOX9 shift of frame, as shown by our data, have the probability of actually truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>SOX9 shift of frame, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>SOX9 shift of frame, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>SOX9 shift of frame, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>SOX9 shift of frame, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>SOX9 shift of frame, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>SOX9 shift of frame, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>SOX9 shift of frame, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>SOX9 shift of frame, such as our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shift of frame</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>SOX9 shifts of frame change actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>SOX9 shifts of frame change actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>SOX9 shifts of frame change can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>SOX9 shifts of frame change can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>SOX9 shifts of frame change frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>SOX9 shifts of frame change frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>SOX9 shifts of frame change frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>SOX9 shifts of frame change has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>SOX9 shifts of frame change has the ability to actually truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>SOX9 shifts of frame change has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>SOX9 shifts of frame change has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>SOX9 shifts of frame change have the probability of actually truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>SOX9 shifts of frame change have the probability of truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>SOX9 shifts of frame change have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>SOX9 shifts of frame change is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>SOX9 shifts of frame change is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>SOX9 shifts of frame change is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>SOX9 shifts of frame change is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>SOX9 shifts of frame change is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>SOX9 shifts of frame change may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>SOX9 shifts of frame change may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>SOX9 shifts of frame change may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>SOX9 shifts of frame change may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>SOX9 shifts of frame change may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>SOX9 shifts of frame change may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>SOX9 shifts of frame change truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>SOX9 shifts of frame change truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>SOX9 shifts of frame change will actually truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>SOX9 shifts of frame change will truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>SOX9 shifts of frame change will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>SOX9 shifts of frame change, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>SOX9 shifts of frame change, as our data show, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>SOX9 shifts of frame change, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>SOX9 shifts of frame change, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>SOX9 shifts of frame change, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>SOX9 shifts of frame change, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>SOX9 shifts of frame change, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>SOX9 shifts of frame change, as our data show, may have truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>SOX9 shifts of frame change, as our data show, truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>SOX9 shifts of frame change, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>SOX9 shifts of frame change, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>SOX9 shifts of frame change, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>SOX9 shifts of frame change, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>SOX9 shifts of frame change, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>SOX9 shifts of frame change, as shown by our data, are able to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>SOX9 shifts of frame change, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>SOX9 shifts of frame change, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>SOX9 shifts of frame change, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>SOX9 shifts of frame change, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>SOX9 shifts of frame change, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>SOX9 shifts of frame change, as shown by our data, has shown to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>SOX9 shifts of frame change, as shown by our data, have the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>SOX9 shifts of frame change, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>SOX9 shifts of frame change, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>SOX9 shifts of frame change, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>SOX9 shifts of frame change, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>SOX9 shifts of frame change, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>SOX9 shifts of frame change, as shown by our data, will truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>SOX9 shifts of frame change, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>SOX9 shifts of frame change, such as our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">SOX9 shifts of frame change</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>The role of A1 N-terminus (M.MspI ), 2-hydroxy-5-nitrobenzyl bromide (HNBB) has been demonstrated to be used to truncate A1 (M.MspI) between residence 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residence 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>The role of A1 N-terminus (M.MspI ), 2-hydroxy-5-nitrobenzyl bromide (HNBB) has been demonstrated to be used to truncate A1 (M.MspI) between residue 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residue 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>To assess the role of A1 N-term (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is able to truncate A1 (M.MspI) between residue 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residue 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>To assess the role of A1 N-term (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is able to truncate A1 (M.MspI) between waste 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">waste 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>To evaluate the role of A1 N-term (M.MspI ), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is observed that A1 (M.MspI) is used to truncate A1 (M.MspI) between residence 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residence 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>To evaluate the role of A1 N-term (M.MspI ), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is observed that A1 (M.MspI) is used to truncate A1 (M.MspI) between residue 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residue 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>To evaluate the role of A1 N-term (M.MspI ), 2-hydroxy-5-nitrobenzyl bromide (HNBB) will be used to truncate A1 (M.MspI) between residue 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residue 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>To evaluate the role of A1 N-term (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) can be used to truncate A1 (M.MspI) between residue 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residue 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>To evaluate the role of A1 N-term (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) can be used to truncate A1 (M.MspI) between waste 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">waste 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>To evaluate the role of A1 N-terminal (M. MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) may have been used to truncate A1 (M. MspI) between residence 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residence 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>To evaluate the role of A1 N-terminal (M. MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) may have been used to truncate A1 (M. MspI) between waste 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">waste 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>To evaluate the role of A1 N-terminal (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is likely to be used to truncate A1 (M.MspI) between residence 34 and 35.</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residence 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>To evaluate the role of A1 N-terminal (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is used to truncate A1 (M.MspI) between residence 34 and 35 to evaluate the role of A1 N-terminal (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is used to trunca</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">residence 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>To evaluate the role of A1 N-terminal (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is used to truncate A1 (M.MspI) between waste 34 and 35 to evaluate the role of A1 N-terminal (M.MspI), 2-hydroxy-5-nitrobenzyl bromide (HNBB) is used to trunca</text>
                    <arg n="0">2-hydroxy-5-nitrobenzyl bromide (HNBB)</arg>
                    <arg n="3">waste 34 and 35</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>frameshift SOX9 actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>frameshift SOX9 actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>frameshift SOX9 actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>frameshift SOX9 can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>frameshift SOX9 can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>frameshift SOX9 can truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>frameshift SOX9 can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>frameshift SOX9 can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>frameshift SOX9 can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>frameshift SOX9 frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>frameshift SOX9 frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>frameshift SOX9 frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>frameshift SOX9 frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>frameshift SOX9 frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>frameshift SOX9 has been shown to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>frameshift SOX9 has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>frameshift SOX9 has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>frameshift SOX9 has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>frameshift SOX9 has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>frameshift SOX9 has the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>frameshift SOX9 have the probability of actually truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>frameshift SOX9 have the probability of actually truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>frameshift SOX9 have the probability of truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>frameshift SOX9 have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>frameshift SOX9 have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>frameshift SOX9 have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>frameshift SOX9 is able to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>frameshift SOX9 is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>frameshift SOX9 is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>frameshift SOX9 is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>frameshift SOX9 is likely to actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>frameshift SOX9 is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>frameshift SOX9 is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>frameshift SOX9 is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>frameshift SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>frameshift SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>frameshift SOX9 is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>frameshift SOX9 is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>frameshift SOX9 may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>frameshift SOX9 may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>frameshift SOX9 may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>frameshift SOX9 may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>frameshift SOX9 may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>frameshift SOX9 may have truncated six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>frameshift SOX9 may have truncated six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>frameshift SOX9 may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>frameshift SOX9 may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>frameshift SOX9 may truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>frameshift SOX9 may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>frameshift SOX9 mutations actually truncated both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>frameshift SOX9 mutations actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>frameshift SOX9 mutations actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>frameshift SOX9 mutations actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>frameshift SOX9 mutations actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>frameshift SOX9 mutations actually truncated their two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>frameshift SOX9 mutations actually truncated their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>frameshift SOX9 mutations can actually truncate both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>frameshift SOX9 mutations can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>frameshift SOX9 mutations can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>frameshift SOX9 mutations can truncate both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>frameshift SOX9 mutations can truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>frameshift SOX9 mutations can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>frameshift SOX9 mutations can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>frameshift SOX9 mutations can truncate their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, is observed to truncate both activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, is observed to truncate six activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, is observed to truncate their two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, truncated both activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>frameshift SOX9 mutations frame change, as shown in our data, truncated their two activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>frameshift SOX9 mutations frame change, like our data, is able to truncate both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>frameshift SOX9 mutations frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>frameshift SOX9 mutations frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>frameshift SOX9 mutations frame change, like our data, is able to truncate their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>frameshift SOX9 mutations has been shown to truncate both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>frameshift SOX9 mutations has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>frameshift SOX9 mutations has been shown to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>frameshift SOX9 mutations has been shown to truncate their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>frameshift SOX9 mutations has been shown to truncate to both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>frameshift SOX9 mutations has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>frameshift SOX9 mutations has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>frameshift SOX9 mutations has been shown to truncate to their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>frameshift SOX9 mutations has the ability to actually truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>frameshift SOX9 mutations has the ability to actually truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>frameshift SOX9 mutations has the ability to actually truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>frameshift SOX9 mutations has the ability to actually truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>frameshift SOX9 mutations has the ability to truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>frameshift SOX9 mutations has the ability to truncate both activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>frameshift SOX9 mutations has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>frameshift SOX9 mutations has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>frameshift SOX9 mutations has the ability to truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>frameshift SOX9 mutations has the ability to truncate their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>frameshift SOX9 mutations have the probability of actually truncating both activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>frameshift SOX9 mutations have the probability of actually truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>frameshift SOX9 mutations have the probability of actually truncating their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>frameshift SOX9 mutations have the probability of truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>frameshift SOX9 mutations have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>frameshift SOX9 mutations have the probability of truncating their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>frameshift SOX9 mutations have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>frameshift SOX9 mutations have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>frameshift SOX9 mutations have truncated their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>frameshift SOX9 mutations is able to actually truncate both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>frameshift SOX9 mutations is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>frameshift SOX9 mutations is able to actually truncate their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>frameshift SOX9 mutations is able to truncate both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>frameshift SOX9 mutations is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>frameshift SOX9 mutations is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>frameshift SOX9 mutations is able to truncate their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>frameshift SOX9 mutations is likely to actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>frameshift SOX9 mutations is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>frameshift SOX9 mutations is likely to actually truncate their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>frameshift SOX9 mutations is likely to truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>frameshift SOX9 mutations is likely to truncate both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>frameshift SOX9 mutations is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>frameshift SOX9 mutations is likely to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>frameshift SOX9 mutations is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>frameshift SOX9 mutations is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>frameshift SOX9 mutations is likely to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>frameshift SOX9 mutations is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>frameshift SOX9 mutations is likely to truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>frameshift SOX9 mutations is likely to truncate their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>frameshift SOX9 mutations is likely to truncate their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>frameshift SOX9 mutations is likely to truncating both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>frameshift SOX9 mutations is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>frameshift SOX9 mutations is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>frameshift SOX9 mutations is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>frameshift SOX9 mutations is likely to truncating their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>frameshift SOX9 mutations is likely to truncating their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>frameshift SOX9 mutations may have truncated both activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>frameshift SOX9 mutations may have truncated both activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>frameshift SOX9 mutations may have truncated both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>frameshift SOX9 mutations may have truncated both activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>frameshift SOX9 mutations may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>frameshift SOX9 mutations may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>frameshift SOX9 mutations may have truncated its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>frameshift SOX9 mutations may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>frameshift SOX9 mutations may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>frameshift SOX9 mutations may have truncated six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>frameshift SOX9 mutations may have truncated their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>frameshift SOX9 mutations may have truncated their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>frameshift SOX9 mutations may have truncated their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>frameshift SOX9 mutations may have truncated their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>frameshift SOX9 mutations may truncate both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>frameshift SOX9 mutations may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>frameshift SOX9 mutations may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>frameshift SOX9 mutations may truncate their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>frameshift SOX9 mutations may truncate their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>frameshift SOX9 mutations truncated both activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>frameshift SOX9 mutations truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>frameshift SOX9 mutations truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>frameshift SOX9 mutations truncated their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>frameshift SOX9 mutations truncated their two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>frameshift SOX9 mutations will actually truncate both activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>frameshift SOX9 mutations will actually truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>frameshift SOX9 mutations will actually truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>frameshift SOX9 mutations will actually truncate their two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>frameshift SOX9 mutations will truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>frameshift SOX9 mutations will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>frameshift SOX9 mutations will truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>frameshift SOX9 mutations will truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>frameshift SOX9 mutations will truncate their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>frameshift SOX9 mutations will truncate their two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>frameshift SOX9 mutations, as our data show, are observed to truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>frameshift SOX9 mutations, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>frameshift SOX9 mutations, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>frameshift SOX9 mutations, as our data show, can truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>frameshift SOX9 mutations, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>frameshift SOX9 mutations, as our data show, can truncate their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>frameshift SOX9 mutations, as our data show, has the ability to truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>frameshift SOX9 mutations, as our data show, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>frameshift SOX9 mutations, as our data show, has the ability to truncate their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>frameshift SOX9 mutations, as our data show, has the probability of truncating both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>frameshift SOX9 mutations, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>frameshift SOX9 mutations, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>frameshift SOX9 mutations, as our data show, has the probability of truncating their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>frameshift SOX9 mutations, as our data show, have the probability of truncating both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>frameshift SOX9 mutations, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>frameshift SOX9 mutations, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>frameshift SOX9 mutations, as our data show, is likely to truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>frameshift SOX9 mutations, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>frameshift SOX9 mutations, as our data show, is likely to truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>frameshift SOX9 mutations, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>frameshift SOX9 mutations, as our data show, it is likely that six activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>frameshift SOX9 mutations, as our data show, it is likely that their two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>frameshift SOX9 mutations, as our data show, may have truncated both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>frameshift SOX9 mutations, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>frameshift SOX9 mutations, as our data show, truncated both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>frameshift SOX9 mutations, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>frameshift SOX9 mutations, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>frameshift SOX9 mutations, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>frameshift SOX9 mutations, as our data show, will truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>frameshift SOX9 mutations, as our data show, will truncate their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>frameshift SOX9 mutations, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>frameshift SOX9 mutations, as our data, are susceptible to truncate their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>frameshift SOX9 mutations, as our data, can truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>frameshift SOX9 mutations, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>frameshift SOX9 mutations, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>frameshift SOX9 mutations, as our data, has the ability to truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>frameshift SOX9 mutations, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>frameshift SOX9 mutations, as our data, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>frameshift SOX9 mutations, as our data, has the ability to truncate their two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>frameshift SOX9 mutations, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>frameshift SOX9 mutations, as shown by our data, actually truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>frameshift SOX9 mutations, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>frameshift SOX9 mutations, as shown by our data, actually truncated their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate both activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>frameshift SOX9 mutations, as shown by our data, are able to truncate their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate both activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate both activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate their two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>frameshift SOX9 mutations, as shown by our data, can truncate their two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>frameshift SOX9 mutations, as shown by our data, has been shown to truncate both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>frameshift SOX9 mutations, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>frameshift SOX9 mutations, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>frameshift SOX9 mutations, as shown by our data, has been shown to truncate their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown that it actually truncates both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown that it actually truncates their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown to truncate both activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>frameshift SOX9 mutations, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>frameshift SOX9 mutations, as shown by our data, have the ability to truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>frameshift SOX9 mutations, as shown by our data, have the ability to truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of actually truncating both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of actually truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of actually truncating their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of truncating both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>frameshift SOX9 mutations, as shown by our data, have the probability of truncating their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>frameshift SOX9 mutations, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>frameshift SOX9 mutations, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>frameshift SOX9 mutations, as shown by our data, have truncated their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to actually truncate both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to actually truncate their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to truncate both activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>frameshift SOX9 mutations, as shown by our data, is observed to truncate their two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>frameshift SOX9 mutations, as shown by our data, may have truncated both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>frameshift SOX9 mutations, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>frameshift SOX9 mutations, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>frameshift SOX9 mutations, as shown by our data, may have truncated their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>frameshift SOX9 mutations, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>frameshift SOX9 mutations, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>frameshift SOX9 mutations, as shown by our data, truncated their two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>frameshift SOX9 mutations, as shown by our data, will actually truncate both activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>frameshift SOX9 mutations, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>frameshift SOX9 mutations, as shown by our data, will actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>frameshift SOX9 mutations, as shown by our data, will actually truncate their two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>frameshift SOX9 mutations, as shown by our data, will truncate both activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>frameshift SOX9 mutations, as shown by our data, will truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>frameshift SOX9 mutations, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>frameshift SOX9 mutations, as shown by our data, will truncate their two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>frameshift SOX9 mutations, like our data, are able to truncate both activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>frameshift SOX9 mutations, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>frameshift SOX9 mutations, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>frameshift SOX9 mutations, like our data, are able to truncate their two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">their two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>frameshift SOX9 mutations, such as our data, can truncate both activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">both activation domains</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>frameshift SOX9 mutations, such as our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>frameshift SOX9 mutations, such as our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>frameshift SOX9 truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>frameshift SOX9 truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>frameshift SOX9 truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>frameshift SOX9 truncated six activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>frameshift SOX9 will actually truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>frameshift SOX9 will actually truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>frameshift SOX9 will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>frameshift SOX9, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>frameshift SOX9, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>frameshift SOX9, as our data show, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>frameshift SOX9, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>frameshift SOX9, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>frameshift SOX9, as our data show, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>frameshift SOX9, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>frameshift SOX9, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>frameshift SOX9, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>frameshift SOX9, as our data show, is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>frameshift SOX9, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>frameshift SOX9, as our data show, it is likely that six activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>frameshift SOX9, as our data show, may have truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>frameshift SOX9, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>frameshift SOX9, as our data show, truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>frameshift SOX9, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>frameshift SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>frameshift SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>frameshift SOX9, as our data show, will truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>frameshift SOX9, as our data show, will truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>frameshift SOX9, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>frameshift SOX9, as our data, are susceptible to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>frameshift SOX9, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>frameshift SOX9, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>frameshift SOX9, as our data, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>frameshift SOX9, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>frameshift SOX9, as our data, may truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>frameshift SOX9, as shown by our data, actually truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>frameshift SOX9, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>frameshift SOX9, as shown by our data, are able to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>frameshift SOX9, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>frameshift SOX9, as shown by our data, are able to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>frameshift SOX9, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>frameshift SOX9, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>frameshift SOX9, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>frameshift SOX9, as shown by our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>frameshift SOX9, as shown by our data, can truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>frameshift SOX9, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>frameshift SOX9, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>frameshift SOX9, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>frameshift SOX9, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>frameshift SOX9, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>frameshift SOX9, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>frameshift SOX9, as shown by our data, have the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>frameshift SOX9, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>frameshift SOX9, as shown by our data, have the probability of actually truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>frameshift SOX9, as shown by our data, have the probability of actually truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>frameshift SOX9, as shown by our data, have the probability of truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>frameshift SOX9, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>frameshift SOX9, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>frameshift SOX9, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>frameshift SOX9, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>frameshift SOX9, as shown by our data, is observed to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>frameshift SOX9, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>frameshift SOX9, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>frameshift SOX9, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>frameshift SOX9, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>frameshift SOX9, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>frameshift SOX9, as shown by our data, will actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>frameshift SOX9, as shown by our data, will truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>frameshift SOX9, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>frameshift SOX9, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>frameshift SOX9, such as our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">frameshift SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>merchshift SOX9 mutations actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>merchshift SOX9 mutations actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>merchshift SOX9 mutations can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>merchshift SOX9 mutations can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>merchshift SOX9 mutations can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>merchshift SOX9 mutations frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>merchshift SOX9 mutations frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>merchshift SOX9 mutations has been shown to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>merchshift SOX9 mutations has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>merchshift SOX9 mutations has the ability to actually truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>merchshift SOX9 mutations has the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>merchshift SOX9 mutations has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>merchshift SOX9 mutations have the probability of actually truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>merchshift SOX9 mutations have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>merchshift SOX9 mutations is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>merchshift SOX9 mutations is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>merchshift SOX9 mutations is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>merchshift SOX9 mutations is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>merchshift SOX9 mutations is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>merchshift SOX9 mutations is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>merchshift SOX9 mutations is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>merchshift SOX9 mutations may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>merchshift SOX9 mutations may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>merchshift SOX9 mutations may have truncated six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>merchshift SOX9 mutations may truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>merchshift SOX9 mutations may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>merchshift SOX9 mutations truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>merchshift SOX9 mutations truncated six activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>merchshift SOX9 mutations will actually truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>merchshift SOX9 mutations will truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>merchshift SOX9 mutations, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>merchshift SOX9 mutations, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>merchshift SOX9 mutations, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>merchshift SOX9 mutations, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>merchshift SOX9 mutations, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>merchshift SOX9 mutations, as our data show, will truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>merchshift SOX9 mutations, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>merchshift SOX9 mutations, as our data, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>merchshift SOX9 mutations, as our data, may truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>merchshift SOX9 mutations, as shown by our data, are able to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>merchshift SOX9 mutations, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>merchshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>merchshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>merchshift SOX9 mutations, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>merchshift SOX9 mutations, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>merchshift SOX9 mutations, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>merchshift SOX9 mutations, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>merchshift SOX9 mutations, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>merchshift SOX9 mutations, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>merchshift SOX9 mutations, as shown by our data, is observed to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>merchshift SOX9 mutations, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>merchshift SOX9 mutations, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>merchshift SOX9 mutations, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>merchshift SOX9 mutations, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>merchshift SOX9 mutations, such as our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">merchshift SOX9 mutations</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>of SOX9 actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>of SOX9 actually truncated the two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>of SOX9 actually truncated the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>of SOX9 can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>of SOX9 can actually truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>of SOX9 can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>of SOX9 can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>of SOX9 can truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>of SOX9 frame change, as shown in our data, is observed to truncate the two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>of SOX9 frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>of SOX9 frame change, like our data, is able to truncate the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>of SOX9 has been shown to truncate the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>of SOX9 has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>of SOX9 has been shown to truncate to the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>of SOX9 has the ability to actually truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>of SOX9 has the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>of SOX9 has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>of SOX9 has the ability to truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>of SOX9 has the ability to truncate the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>of SOX9 have the probability of actually truncating the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>of SOX9 have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>of SOX9 have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>of SOX9 have truncated the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>of SOX9 is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>of SOX9 is able to truncate the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>of SOX9 is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>of SOX9 is likely to actually truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>of SOX9 is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>of SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>of SOX9 is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>of SOX9 is likely to truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>of SOX9 is likely to truncate the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>of SOX9 is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>of SOX9 is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>of SOX9 is likely to truncating the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>of SOX9 is likely to truncating the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>of SOX9 may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>of SOX9 may have truncated six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>of SOX9 may have truncated the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>of SOX9 may have truncated the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>of SOX9 may have truncated the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>of SOX9 may truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>of SOX9 may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>of SOX9 may truncate the two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>of SOX9 may truncate the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>of SOX9 truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>of SOX9 truncated six activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>of SOX9 truncated the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>of SOX9 truncated the two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>of SOX9 will actually truncate the two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>of SOX9 will truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>of SOX9 will truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>of SOX9 will truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>of SOX9 will truncate the two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>of SOX9, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>of SOX9, as our data show, are observed to truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>of SOX9, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>of SOX9, as our data show, has the ability to truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>of SOX9, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>of SOX9, as our data show, has the probability of truncating the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>of SOX9, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>of SOX9, as our data show, have the probability of truncating the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>of SOX9, as our data show, is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>of SOX9, as our data show, is likely to truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>of SOX9, as our data show, it is likely that six activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>of SOX9, as our data show, it is likely that the two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>of SOX9, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>of SOX9, as our data show, may have truncated the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>of SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>of SOX9, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>of SOX9, as our data show, truncated the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>of SOX9, as our data show, truncated the two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>of SOX9, as our data show, will truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>of SOX9, as our data show, will truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>of SOX9, as our data, are susceptible to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>of SOX9, as our data, are susceptible to truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>of SOX9, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>of SOX9, as our data, has the ability to truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>of SOX9, as our data, may truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>of SOX9, as our data, may truncate the two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>of SOX9, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>of SOX9, as shown by our data, actually truncated the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>of SOX9, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>of SOX9, as shown by our data, are able to truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>of SOX9, as shown by our data, are able to truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>of SOX9, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>of SOX9, as shown by our data, can truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>of SOX9, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>of SOX9, as shown by our data, can truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>of SOX9, as shown by our data, can truncate the two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>of SOX9, as shown by our data, can truncate the two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>of SOX9, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>of SOX9, as shown by our data, has been shown to truncate the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>of SOX9, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>of SOX9, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>of SOX9, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>of SOX9, as shown by our data, have the ability to truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>of SOX9, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>of SOX9, as shown by our data, have the probability of truncating the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>of SOX9, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>of SOX9, as shown by our data, have truncated the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>of SOX9, as shown by our data, is observed to actually truncate the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>of SOX9, as shown by our data, is observed to truncate the two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>of SOX9, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>of SOX9, as shown by our data, truncated the two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>of SOX9, as shown by our data, will actually truncate the two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>of SOX9, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>of SOX9, as shown by our data, will truncate the two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>of SOX9, like our data, are able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>of SOX9, such as our data, can truncate the two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">of SOX9</arg>
                    <arg n="2">the two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>soX9 shift frame changes actually truncated its two activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>soX9 shift frame changes actually truncated its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>soX9 shift frame changes actually truncated six activation domains while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>soX9 shift frame changes actually truncated six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>soX9 shift frame changes can actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>soX9 shift frame changes can actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>soX9 shift frame changes can truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>soX9 shift frame changes can truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>soX9 shift frame changes can truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>soX9 shift frame changes can truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>soX9 shift frame changes frame change, as shown in our data, is observed to truncate its two activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>soX9 shift frame changes frame change, as shown in our data, is observed to truncate six activation domains, while all the reported absent mutations are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>soX9 shift frame changes frame change, as shown in our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>soX9 shift frame changes frame change, like our data, is able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>soX9 shift frame changes frame change, like our data, is able to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>soX9 shift frame changes has been shown to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>soX9 shift frame changes has been shown to truncate to its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>soX9 shift frame changes has been shown to truncate to six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>soX9 shift frame changes has the ability to actually truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>soX9 shift frame changes has the ability to actually truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>soX9 shift frame changes has the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>soX9 shift frame changes has the ability to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>soX9 shift frame changes has the ability to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>soX9 shift frame changes have the probability of actually truncating its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>soX9 shift frame changes have the probability of actually truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>soX9 shift frame changes have the probability of truncating six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>soX9 shift frame changes have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>soX9 shift frame changes have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>soX9 shift frame changes is able to actually truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>soX9 shift frame changes is able to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>soX9 shift frame changes is able to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>soX9 shift frame changes is likely to actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>soX9 shift frame changes is likely to actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>soX9 shift frame changes is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>soX9 shift frame changes is likely to truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>soX9 shift frame changes is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>soX9 shift frame changes is likely to truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>soX9 shift frame changes is likely to truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>soX9 shift frame changes is likely to truncating its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>soX9 shift frame changes is likely to truncating its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>soX9 shift frame changes is likely to truncating six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>soX9 shift frame changes is likely to truncating six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>soX9 shift frame changes may have truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>soX9 shift frame changes may have truncated its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>soX9 shift frame changes may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>soX9 shift frame changes may have truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>soX9 shift frame changes may have truncated six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>soX9 shift frame changes may truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>soX9 shift frame changes may truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>soX9 shift frame changes may truncate six activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>soX9 shift frame changes may truncate six activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>soX9 shift frame changes truncated its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>soX9 shift frame changes truncated its two activation domains, while all the missing mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>soX9 shift frame changes truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>soX9 shift frame changes will actually truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>soX9 shift frame changes will actually truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>soX9 shift frame changes will truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>soX9 shift frame changes will truncate its two activation domains, while all the missing mutations reported so far fall within the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>soX9 shift frame changes, as our data show, are observed to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>soX9 shift frame changes, as our data show, are observed to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>soX9 shift frame changes, as our data show, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>soX9 shift frame changes, as our data show, has the ability to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>soX9 shift frame changes, as our data show, has the ability to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>soX9 shift frame changes, as our data show, has the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>soX9 shift frame changes, as our data show, has the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>soX9 shift frame changes, as our data show, have the probability of truncating its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>soX9 shift frame changes, as our data show, have the probability of truncating six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>soX9 shift frame changes, as our data show, is likely to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>soX9 shift frame changes, as our data show, is likely to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>soX9 shift frame changes, as our data show, it is likely that its two activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>soX9 shift frame changes, as our data show, it is likely that six activation domains is actually truncated, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>soX9 shift frame changes, as our data show, may have truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>soX9 shift frame changes, as our data show, may have truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>soX9 shift frame changes, as our data show, truncated its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>soX9 shift frame changes, as our data show, truncated its two activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>soX9 shift frame changes, as our data show, truncated six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>soX9 shift frame changes, as our data show, truncated six activation domains, while all the absent mutations reported so far were in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>soX9 shift frame changes, as our data show, will truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>soX9 shift frame changes, as our data, are susceptible to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>soX9 shift frame changes, as our data, can truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>soX9 shift frame changes, as our data, can truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>soX9 shift frame changes, as our data, may truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>soX9 shift frame changes, as shown by our data, actually truncated six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>soX9 shift frame changes, as shown by our data, are able to truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>soX9 shift frame changes, as shown by our data, are able to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>soX9 shift frame changes, as shown by our data, are able to truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>soX9 shift frame changes, as shown by our data, can truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>soX9 shift frame changes, as shown by our data, can truncate its two activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>soX9 shift frame changes, as shown by our data, can truncate its two activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>soX9 shift frame changes, as shown by our data, can truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>soX9 shift frame changes, as shown by our data, can truncate six activation domains, while all incorrect-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>soX9 shift frame changes, as shown by our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>soX9 shift frame changes, as shown by our data, has been shown to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>soX9 shift frame changes, as shown by our data, has been shown to truncate six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>soX9 shift frame changes, as shown by our data, has shown that it actually truncates its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>soX9 shift frame changes, as shown by our data, has shown that it actually truncates six activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>soX9 shift frame changes, as shown by our data, has shown to truncate its two activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>soX9 shift frame changes, as shown by our data, has shown to truncate six activation domains, while all the absent mutations reported so far are in the high mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>soX9 shift frame changes, as shown by our data, have the ability to truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>soX9 shift frame changes, as shown by our data, have the ability to truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>soX9 shift frame changes, as shown by our data, have the probability of actually truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>soX9 shift frame changes, as shown by our data, have the probability of truncating its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>soX9 shift frame changes, as shown by our data, have the probability of truncating six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>soX9 shift frame changes, as shown by our data, have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>soX9 shift frame changes, as shown by our data, have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>soX9 shift frame changes, as shown by our data, is observed to actually truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>soX9 shift frame changes, as shown by our data, is observed to truncate its two activation domains, while all counter-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>soX9 shift frame changes, as shown by our data, may have truncated its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>soX9 shift frame changes, as shown by our data, may have truncated six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>soX9 shift frame changes, as shown by our data, truncated its two activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>soX9 shift frame changes, as shown by our data, truncated six activation domains, while all remaining mutations reported so far were in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>soX9 shift frame changes, as shown by our data, will actually truncate its two activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>soX9 shift frame changes, as shown by our data, will actually truncate six activation domains, while all missense mutations reported to date are in the high-mobility group DNA-binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>soX9 shift frame changes, as shown by our data, will truncate its two activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>soX9 shift frame changes, as shown by our data, will truncate six activation domains, while all common-sense mutations reported to date are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>soX9 shift frame changes, like our data, are able to truncate its two activation domains, while all the missing mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">its two activation domains</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>soX9 shift frame changes, such as our data, can truncate six activation domains, while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">soX9 shift frame changes</arg>
                    <arg n="2">six activation domains</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Almost all A0 mutations (TSC1) are found as dramatically truncated the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Almost all A0 mutations (TSC1) are found to truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Almost all A0 mutations (TSC1) are found to truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Almost all A0 mutations (TSC1) are found to truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Almost all A0 mutations (TSC1) are found to truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Almost all A0 mutations (TSC1) are found to truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Almost all A0 mutations (TSC1) are found to truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Almost all A0 mutations (TSC1) are found to truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Almost all A0 mutations (TSC1) are found to truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Almost all A0 mutations (TSC1) are found to truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Almost all A0 mutations (TSC1) are found to truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Almost all A0 mutations (TSC1) have dramatically truncated the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Almost all a gene orientation approach mutations have truncated the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Almost all a genetic direction approach mutations have truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Almost all altered post-synaptic density level 95 (PSD95) isoforms mutations have truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Almost all altered postsynaptic density 95 (PSD95) isoforms mutations have truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Almost all altered postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>Almost all altered the post-synaptic density level 95 (PSD95) isoformes mutations have truncated protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>Almost all altered the postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>Almost all alternate postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>Almost all alternated postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and PVR that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Stat5a proteins truncated by C-terminal that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Stat5a proteins truncated by C-terminally that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Stat5a truncated proteins C that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Stat5a truncated proteins by C that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Strat5a proteins truncated by C-terminally that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Strat5a truncated by C-terminally that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and Strat5a truncated proteins by C that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and a bacterially expressed protein that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and a protein expressed bacteria that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and a protein expressed by bacteria that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and a protein expressing bacteria that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and protein that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and the Stat5a molecule that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and the molecule Stat5a that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>Electrophoric mobility tests showed that the total length of the BCL6 protein extracted from infected body cells and the receptor that contains the BCL6 zinc fingers and that has been strongly truncated can specifically bind to the DNA of the HIV-1 U3 promoter/valuer region.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>For the generation of this protein, PVR can be truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>For the generation of this protein, PVR can be truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>For the generation of this protein, PVR can be truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>For the generation of this protein, PVR can be truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>For the generation of this protein, PVR can be truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>For the generation of this protein, PVR can be truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>For the generation of this protein, PVR can be truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>For the generation of this protein, PVR can be truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>For the generation of this protein, PVR can be truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>For the generation of this protein, PVR is able to be truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>For the generation of this protein, PVR is able to be truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>For the generation of this protein, PVR is able to be truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>For the generation of this protein, PVR is able to be truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>For the generation of this protein, PVR is able to be truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>For the generation of this protein, PVR is able to be truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>For the generation of this protein, PVR is able to be truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>For the generation of this protein, PVR is able to be truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>For the generation of this protein, PVR is able to be truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>For the generation of this protein, PVR is able to be truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>For the generation of this protein, PVR is likely to be truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>For the generation of this protein, PVR is likely to be truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>For the generation of this protein, PVR is likely to be truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>For the generation of this protein, PVR is likely to be truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>For the generation of this protein, PVR is truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>For the generation of this protein, PVR is truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>For the generation of this protein, PVR is truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>For the generation of this protein, PVR is truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>For the generation of this protein, PVR is truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>For the generation of this protein, PVR is truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>For the generation of this protein, PVR is truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>For the generation of this protein, PVR is truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>For the generation of this protein, PVR is truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>For the generation of this protein, PVR may have been truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>For the generation of this protein, PVR may have been truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>For the generation of this protein, PVR may have been truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>For the generation of this protein, PVR may have been truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>For the generation of this protein, PVR may have been truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>For the generation of this protein, PVR may have been truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>For the generation of this protein, PVR may have been truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>For the generation of this protein, PVR may have been truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>For the generation of this protein, PVR may have been truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>For the generation of this protein, PVR was truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>For the generation of this protein, PVR was truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>For the generation of this protein, PVR was truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>For the generation of this protein, PVR was truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>For the generation of this protein, PVR will be truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>For the generation of this protein, PVR will be truncated before P motif (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>For the generation of this protein, PVR will be truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>For the generation of this protein, PVR will be truncated before PP-motif (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>For the generation of this protein, PVR will be truncated before PP-reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>For the generation of this protein, PVR will be truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>For the generation of this protein, PVR will be truncated before the PP reason (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>For the generation of this protein, PVR will be truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>For the generation of this protein, PVR will be truncated before the PP-motif (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>For the generation of this protein, Stat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>For the generation of this protein, Stat5a truncated proteins C can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>For the generation of this protein, Stat5a truncated proteins C can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>For the generation of this protein, Stat5a truncated proteins C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>For the generation of this protein, Stat5a truncated proteins C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>For the generation of this protein, Stat5a truncated proteins C is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>For the generation of this protein, Stat5a truncated proteins C is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>For the generation of this protein, Stat5a truncated proteins C is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>For the generation of this protein, Stat5a truncated proteins C may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>For the generation of this protein, Stat5a truncated proteins C may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>For the generation of this protein, Stat5a truncated proteins C was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>For the generation of this protein, Stat5a truncated proteins C will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>For the generation of this protein, Stat5a truncated proteins by C can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>For the generation of this protein, Stat5a truncated proteins by C can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>For the generation of this protein, Stat5a truncated proteins by C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>For the generation of this protein, Stat5a truncated proteins by C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>For the generation of this protein, Stat5a truncated proteins by C is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>For the generation of this protein, Stat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>For the generation of this protein, Stat5a truncated proteins by C may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>For the generation of this protein, Stat5a truncated proteins by C will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>For the generation of this protein, State 5th C truncated proteins can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>For the generation of this protein, State 5th C truncated proteins can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>For the generation of this protein, State 5th C truncated proteins is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>For the generation of this protein, State 5th C truncated proteins is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>For the generation of this protein, State 5th C truncated proteins is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>For the generation of this protein, State 5th C truncated proteins is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>For the generation of this protein, State 5th C truncated proteins is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>For the generation of this protein, State 5th C truncated proteins may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>For the generation of this protein, State 5th C truncated proteins was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>For the generation of this protein, State 5th C truncated proteins will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>For the generation of this protein, State 5th C truncated proteins will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>For the generation of this protein, Strat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>For the generation of this protein, Strat5a truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>For the generation of this protein, Strat5a truncated proteins by C can be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>For the generation of this protein, Strat5a truncated proteins by C can be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>For the generation of this protein, Strat5a truncated proteins by C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>For the generation of this protein, Strat5a truncated proteins by C is able to be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>For the generation of this protein, Strat5a truncated proteins by C is likely to be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>For the generation of this protein, Strat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>For the generation of this protein, Strat5a truncated proteins by C may have been truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>For the generation of this protein, Strat5a truncated proteins by C may have been truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>For the generation of this protein, Strat5a truncated proteins by C was truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>For the generation of this protein, Strat5a truncated proteins by C will be truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>For the generation of this protein, Strat5a truncated proteins by C will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>For the generation of this protein, it is likely that PVR will be truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>For the generation of this protein, it is likely that Stat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>For the generation of this protein, it is likely that Stat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>For the generation of this protein, it is likely that Stat5a truncated proteins C will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>For the generation of this protein, it is likely that Strat5a proteins truncated by C-terminal will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>For the generation of this protein, it is likely that Strat5a proteins truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>For the generation of this protein, it is likely that Strat5a truncated by C-terminally will be truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>For the generation of this protein, it is observed that PVR is truncated before P motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>For the generation of this protein, it is observed that PVR is truncated before P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>For the generation of this protein, it is observed that PVR is truncated before PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>For the generation of this protein, it is observed that PVR is truncated before PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>For the generation of this protein, it is observed that PVR is truncated before PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>For the generation of this protein, it is observed that PVR is truncated before the PP reason (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>For the generation of this protein, it is observed that PVR is truncated before the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>For the generation of this protein, it is observed that PVR is truncated before the PP-motif (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>For the generation of this protein, it is observed that Stat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>For the generation of this protein, it is observed that Stat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>For the generation of this protein, it is observed that Stat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>For the generation of this protein, it is observed that Stat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>For the generation of this protein, it is observed that Stat5a truncated proteins C is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>For the generation of this protein, it is observed that Stat5a truncated proteins C is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>For the generation of this protein, it is observed that Stat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>For the generation of this protein, it is observed that Stat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>For the generation of this protein, it is observed that Strat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>For the generation of this protein, it is observed that Strat5a proteins truncated by C-terminal is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>For the generation of this protein, it is observed that Strat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>For the generation of this protein, it is observed that Strat5a proteins truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>For the generation of this protein, it is observed that Strat5a truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>For the generation of this protein, it is observed that Strat5a truncated by C-terminally is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>For the generation of this protein, it is observed that Strat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present at the junction between domains 2 and 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>For the generation of this protein, it is observed that Strat5a truncated proteins by C is truncated before amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>For the generation of this protein, the PVR is thought to be truncated before the P motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>For the generation of this protein, the PVR is thought to be truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>For the generation of this protein, the PVR is thought to be truncated before the PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>For the generation of this protein, the PVR is thought to be truncated before the the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>For the generation of this protein, the PVR is thought to be truncated before the the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>For the generation of this protein, the PVR was truncated before the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>For the generation of this protein, the PVR was truncated before the PP-reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>For the generation of this protein, the PVR was truncated before the the PP reason (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>For the generation of this protein, the PVR was truncated before the the PP-motif (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>For the generation of this protein, the Stat5a proteins truncated by C-terminal is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>For the generation of this protein, the Stat5a proteins truncated by C-terminal was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>For the generation of this protein, the Stat5a proteins truncated by C-terminally is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>For the generation of this protein, the Stat5a proteins truncated by C-terminally was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>For the generation of this protein, the Stat5a truncated proteins C is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>For the generation of this protein, the Stat5a truncated proteins C was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>For the generation of this protein, the Stat5a truncated proteins by C is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>For the generation of this protein, the Stat5a truncated proteins by C was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>For the generation of this protein, the State 5th C truncated proteins is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>For the generation of this protein, the Strat5a proteins truncated by C-terminal is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>For the generation of this protein, the Strat5a proteins truncated by C-terminal was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>For the generation of this protein, the Strat5a proteins truncated by C-terminally is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>For the generation of this protein, the Strat5a proteins truncated by C-terminally was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>For the generation of this protein, the Strat5a truncated by C-terminally is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>For the generation of this protein, the Strat5a truncated by C-terminally was truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>For the generation of this protein, the Strat5a truncated proteins by C is thought to be truncated before the amino acids 762 or 773 (`PP-motif_) present in the binding of domains 2 to 3 (figure 1).</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>Most of the alterations found were the truncation PVR through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>Most of the alterations found were the truncation Stat5a proteins truncated by C-terminal through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>Most of the alterations found were the truncation Stat5a proteins truncated by C-terminally through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>Most of the alterations found were the truncation Stat5a truncated proteins C through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>Most of the alterations found were the truncation State 5th C truncated proteins through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>Most of the alterations found were the truncation Strat5a proteins truncated by C-terminal through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>Most of the alterations found were the truncation Strat5a proteins truncated by C-terminally through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>Most of the alterations found were the truncation Strat5a truncated by C-terminally through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>Most of the alterations found were the truncation Strat5a truncated proteins by C through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>Most of the alterations found were the truncation a bacterially expressed protein through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>Most of the alterations found were the truncation a protein expressed bacteria through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>Most of the alterations found were the truncation a protein expressed by bacteria through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>Most of the alterations found were the truncation a protein expressing bacteria through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>Most of the alterations found were the truncation protein through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>Most of the alterations found were the truncation the molecule Stat5a through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>Most of the alterations found were the truncation the receptor through A0 (senseless mutations (32%), insertions or deletions (29.6%) or truncate alterations (6.2%), although the values were biased by the methods used, and in sequenced areas, about 50% of all mutations were absent or on table.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>Practically all A0 mutations (TSC1) are able to dramatically truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>Practically all A0 mutations (TSC1) are able to truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>Practically all A0 mutations (TSC1) are able to truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>Practically all A0 mutations (TSC1) are able to truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>Practically all A0 mutations (TSC1) are able to truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>Practically all A0 mutations (TSC1) are able to truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>Practically all A0 mutations (TSC1) are able to truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>Practically all A0 mutations (TSC1) are able to truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>Practically all A0 mutations (TSC1) are able to truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>Practically all A0 mutations (TSC1) are able to truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>Practically all A0 mutations (TSC1) can truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>Practically all A0 mutations (TSC1) can truncate Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>Practically all A0 mutations (TSC1) can truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>Practically all A0 mutations (TSC1) can truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>Practically all A0 mutations (TSC1) can truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>Practically all A0 mutations (TSC1) can truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>Practically all A0 mutations (TSC1) can truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>Practically all A0 mutations (TSC1) can truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>Practically all A0 mutations (TSC1) can truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>Practically all A0 mutations (TSC1) can truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>Practically all A0 mutations (TSC1) can truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>Practically all A0 mutations (TSC1) can truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>Practically all A0 mutations (TSC1) can truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>Practically all A0 mutations (TSC1) can truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>Practically all A0 mutations (TSC1) can truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>Practically all A0 mutations (TSC1) can truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>Practically all A0 mutations (TSC1) can truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>Practically all A0 mutations (TSC1) can truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>Practically all A0 mutations (TSC1) have the ability to dramatically truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>Practically all A0 mutations (TSC1) have the ability to truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>Practically all A0 mutations (TSC1) may dramatically truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>Practically all A0 mutations (TSC1) may have dramatically truncated the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>Practically all A0 mutations (TSC1) may have truncated PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>Practically all A0 mutations (TSC1) may have truncated Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>Practically all A0 mutations (TSC1) may have truncated Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>Practically all A0 mutations (TSC1) may have truncated Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>Practically all A0 mutations (TSC1) may have truncated State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>Practically all A0 mutations (TSC1) may have truncated Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>Practically all A0 mutations (TSC1) may have truncated Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>Practically all A0 mutations (TSC1) may have truncated Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>Practically all A0 mutations (TSC1) may have truncated Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>Practically all A0 mutations (TSC1) may have truncated a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>Practically all A0 mutations (TSC1) may have truncated a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>Practically all A0 mutations (TSC1) may have truncated a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>Practically all A0 mutations (TSC1) may have truncated protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>Practically all A0 mutations (TSC1) may have truncated the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>Practically all A0 mutations (TSC1) may have truncated the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>Practically all A0 mutations (TSC1) truncated PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>Practically all A0 mutations (TSC1) truncated Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>Practically all A0 mutations (TSC1) truncated Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>Practically all A0 mutations (TSC1) truncated Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>Practically all A0 mutations (TSC1) truncated State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>Practically all A0 mutations (TSC1) truncated Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>Practically all A0 mutations (TSC1) truncated Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>Practically all A0 mutations (TSC1) truncated Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>Practically all A0 mutations (TSC1) truncated a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>Practically all A0 mutations (TSC1) truncated a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>Practically all A0 mutations (TSC1) truncated a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>Practically all A0 mutations (TSC1) truncated dramatically the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>Practically all A0 mutations (TSC1) truncated protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>Practically all A0 mutations (TSC1) truncated the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>Practically all A0 mutations (TSC1) truncated the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>Practically all A0 mutations (TSC1) truncated the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>Practically all A0 mutations (TSC1) were predicted to dramatically truncate the receptor.</text>
                    <arg n="1">the receptor</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate State 5th C truncated proteins.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Strat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Strat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>Practically all A0 mutations (TSC1) will dramatically truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>Practically all A0 mutations (TSC1) will truncate PVR.</text>
                    <arg n="1">PVR</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>Practically all A0 mutations (TSC1) will truncate Stat5a proteins truncated by C-terminal.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>Practically all A0 mutations (TSC1) will truncate Stat5a proteins truncated by C-terminally.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>Practically all A0 mutations (TSC1) will truncate Stat5a truncated proteins C.</text>
                    <arg n="1">Stat5a truncated proteins C</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>Practically all A0 mutations (TSC1) will truncate Stat5a truncated proteins by C.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>Practically all A0 mutations (TSC1) will truncate Strat5a truncated by C-terminally.</text>
                    <arg n="1">Strat5a truncated by C-terminally</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>Practically all A0 mutations (TSC1) will truncate Strat5a truncated proteins by C.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>Practically all A0 mutations (TSC1) will truncate a bacterially expressed protein.</text>
                    <arg n="1">a bacterially expressed protein</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>Practically all A0 mutations (TSC1) will truncate a protein expressed bacteria.</text>
                    <arg n="1">a protein expressed bacteria</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>Practically all A0 mutations (TSC1) will truncate a protein expressed by bacteria.</text>
                    <arg n="1">a protein expressed by bacteria</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>Practically all A0 mutations (TSC1) will truncate a protein expressing bacteria.</text>
                    <arg n="1">a protein expressing bacteria</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>Practically all A0 mutations (TSC1) will truncate protein.</text>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>Practically all A0 mutations (TSC1) will truncate the Stat5a molecule.</text>
                    <arg n="1">the Stat5a molecule</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>Practically all A0 mutations (TSC1) will truncate the molecule Stat5a.</text>
                    <arg n="1">the molecule Stat5a</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>Practically all a gene orientation approach mutations are able to dramatically truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>Practically all a gene orientation approach mutations are able to truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>Practically all a gene orientation approach mutations can dramatically truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>Practically all a gene orientation approach mutations can truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>Practically all a gene orientation approach mutations have been predicted to dramatically truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>Practically all a gene orientation approach mutations have been predicted to truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>Practically all a gene orientation approach mutations have dramatically truncated the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>Practically all a gene orientation approach mutations have the ability to dramatically truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>Practically all a gene orientation approach mutations have the ability to truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>Practically all a gene orientation approach mutations have truncated the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>Practically all a gene orientation approach mutations may have dramatically truncated the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>Practically all a gene orientation approach mutations truncated the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>Practically all a gene orientation approach mutations were predicted to truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>Practically all a gene orientation approach mutations will dramatically truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>Practically all a genetic direction approach mutations are able to dramatically truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>Practically all a genetic direction approach mutations can dramatically truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>Practically all a genetic direction approach mutations dramatically truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>Practically all a genetic direction approach mutations have been predicted to truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>Practically all a genetic direction approach mutations have dramatically truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>Practically all a genetic direction approach mutations have the ability to dramatically truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>Practically all a genetic direction approach mutations have the ability to truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>Practically all a genetic direction approach mutations have truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>Practically all a genetic direction approach mutations may have dramatically truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>Practically all a genetic direction approach mutations may have truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>Practically all a genetic direction approach mutations truncated the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>Practically all a genetic direction approach mutations were predicted to truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>Practically all a genetic direction approach mutations will dramatically truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations are able to dramatically truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations are able to truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations can truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations dramatically truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations have been predicted to dramatically truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations have been predicted to truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations have dramatically truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations have the ability to dramatically truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations have truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations may have dramatically truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations may have truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations truncated protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>Practically all altered post-synaptic density level 95 (PSD95) isoforms mutations were predicted to truncate protein.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations are able to dramatically truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations are able to dramatically truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations are able to truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations can dramatically truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations can dramatically truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations can truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations can truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations dramatically truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations dramatically truncated the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have been predicted to dramatically truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have been predicted to truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have been predicted to truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have dramatically truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have dramatically truncated the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have the ability to dramatically truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have the ability to dramatically truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have the ability to truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations may have dramatically truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations may have truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations truncated protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations truncated the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations were predicted to truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations were predicted to truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations will dramatically truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>Practically all altered postsynaptic density 95 (PSD95) isoforms mutations will dramatically truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations are able to truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations can dramatically truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations can truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations dramatically truncated protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations have been predicted to dramatically truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations have been predicted to truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations have the ability to dramatically truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations have the ability to truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations have truncated protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations may have dramatically truncated protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations truncated protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations were predicted to truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>Practically all altered the post-synaptic density level 95 (PSD95) isoformes mutations will dramatically truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations are able to dramatically truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations are able to truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations can truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations dramatically truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have been predicted to dramatically truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have been predicted to truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have dramatically truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have the ability to dramatically truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have the ability to truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations may have dramatically truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations may have truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations truncated the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="577">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations were predicted to truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="578">
                    <text>Practically all altered the postsynaptic density 95 (PSD95) isoforms mutations will dramatically truncate the protein.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="579">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations are able to dramatically truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="580">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations are able to truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="581">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations can dramatically truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="582">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations can truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="583">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations dramatically truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="584">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations have been predicted to dramatically truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="585">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations have been predicted to truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="586">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations have dramatically truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="587">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="588">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations may have dramatically truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="589">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations truncated the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="590">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations were predicted to truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="591">
                    <text>Practically all alternate postsynaptic density 95 (PSD95) isoforms mutations will dramatically truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="592">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations are able to dramatically truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="593">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations are able to truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="594">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations can dramatically truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="595">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations can truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="596">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations dramatically truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="597">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations have been predicted to truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="598">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations have dramatically truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="599">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations have the ability to dramatically truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="600">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations have the ability to truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="601">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations have truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="602">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations may have dramatically truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="603">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations may have truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="604">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations truncated the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="605">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations were predicted to truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="606">
                    <text>Practically all alternated postsynaptic density 95 (PSD95) isoforms mutations will dramatically truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="607">
                    <text>Practically all mutations a gene orientation approach will truncate the titin gene.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="608">
                    <text>Practically all mutations a genetic direction approach will truncate the titin gene.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="609">
                    <text>Practically all mutations altered postsynaptic density 95 (PSD95) isoforms will truncate protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="610">
                    <text>Practically all mutations altered postsynaptic density 95 (PSD95) isoforms will truncate the protein.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="611">
                    <text>Practically all mutations altered the post-synaptic density level 95 (PSD95) isoformes will truncate protein.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="612">
                    <text>Practically all mutations alternate postsynaptic density 95 (PSD95) isoforms will truncate the protein.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="613">
                    <text>Practically all mutations alternated postsynaptic density 95 (PSD95) isoforms will truncate the protein.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="614">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="615">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="616">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="617">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="618">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="619">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="620">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a gene orientation approach and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="621">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="622">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="623">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="624">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="625">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="626">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="627">
                    <text>Previous studies using the Encephalomyocarditis Virus Type a genetic direction approach and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="628">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="629">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="630">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="631">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="632">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="633">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="634">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="635">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="636">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="637">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="638">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="639">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="640">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="641">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="642">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="643">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="644">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="645">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="646">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="647">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="648">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="649">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="650">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="651">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="652">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="653">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="654">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="655">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="656">
                    <text>Previous studies using the Encephalomyocarditis Virus Type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="657">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="658">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="659">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="660">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="661">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="662">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="663">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="664">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="665">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="666">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="667">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which may have been genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="668">
                    <text>Previous studies using the Encephalomyocarditis Virus Type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="669">
                    <text>Previous studies using the Encephalomyocarditis Virus type a gene orientation approach and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="670">
                    <text>Previous studies using the Encephalomyocarditis Virus type a genetic direction approach and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="671">
                    <text>Previous studies using the Encephalomyocarditis Virus type a genetic direction approach and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="672">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="673">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="674">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="675">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="676">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="677">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="678">
                    <text>Previous studies using the Encephalomyocarditis Virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="679">
                    <text>Previous studies using the Encephalomyocarditis Virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="680">
                    <text>Previous studies using the Encephalomyocarditis Virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="681">
                    <text>Previous studies using the Encephalomyocarditis Virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are probably genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="682">
                    <text>Previous studies using the Encephalomyocarditis Virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses, which are likely to be genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="683">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="684">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="685">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="686">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="687">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="688">
                    <text>Previous studies using the Encephalomyocarditis virus type a gene orientation approach and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="689">
                    <text>Previous studies using the Encephalomyocarditis virus type a genetic direction approach and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="690">
                    <text>Previous studies using the Encephalomyocarditis virus type a genetic direction approach and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="691">
                    <text>Previous studies using the Encephalomyocarditis virus type a genetic direction approach and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="692">
                    <text>Previous studies using the Encephalomyocarditis virus type a genetic direction approach and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the titin gene produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="693">
                    <text>Previous studies using the Encephalomyocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="694">
                    <text>Previous studies using the Encephalomyocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="695">
                    <text>Previous studies using the Encephalomyocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="696">
                    <text>Previous studies using the Encephalomyocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="697">
                    <text>Previous studies using the Encephalomyocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="698">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="699">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="700">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="701">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="702">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="703">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="704">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="705">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="706">
                    <text>Previous studies using the Encephalomyocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="707">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="708">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="709">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="710">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="711">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="712">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="713">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="714">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="715">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="716">
                    <text>Previous studies using the Encephalomyocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="717">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="718">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="719">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="720">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="721">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="722">
                    <text>Previous studies using the Encephalomyocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="723">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that genetic engineering is able to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="724">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), observed that they are genetically engineers to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="725">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to replace or truncate the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="726">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which are observed as genetic engineering to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="727">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses ), which were genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="728">
                    <text>Previous studies using the Encephalomyocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and the Mengo virus, and variants of these viruses) which will be genetically designed to truncate or replace the protein produced conflicting data on the role of the poly(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="729">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, have been shown to replace or truncate the titin gene to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="730">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="731">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="732">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="733">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="734">
                    <text>Previous studies using the encephalomiocarditis virus type a gene orientation approach and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a gene orientation approach</arg>
                </example>
                <example src="REPLACE" no="735">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, have been shown to replace or truncate the titin gene to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                    <arg n="1">the titin gene</arg>
                </example>
                <example src="REPLACE" no="736">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="737">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="738">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="739">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="740">
                    <text>Previous studies using the encephalomiocarditis virus type a genetic direction approach and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="741">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, have been shown to replace or truncate protein to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="742">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="743">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="744">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="745">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="746">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="747">
                    <text>Previous studies using the encephalomiocarditis virus type altered post-synaptic density level 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered post-synaptic density level 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="748">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, have been shown to replace or truncate protein to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="749">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, have been shown to replace or truncate the protein to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="750">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="751">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="752">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="753">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="754">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="755">
                    <text>Previous studies using the encephalomiocarditis virus type altered postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="756">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, have been shown to replace or truncate protein to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                    <arg n="1">protein</arg>
                </example>
                <example src="REPLACE" no="757">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="758">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="759">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="760">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="761">
                    <text>Previous studies using the encephalomiocarditis virus type altered the post-synaptic density level 95 (PSD95) isoformes and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="762">
                    <text>Previous studies using the encephalomiocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="763">
                    <text>Previous studies using the encephalomiocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="764">
                    <text>Previous studies using the encephalomiocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="765">
                    <text>Previous studies using the encephalomiocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="766">
                    <text>Previous studies using the encephalomiocarditis virus type altered the postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="767">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, have been shown to replace or truncate the protein to produce conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                    <arg n="1">the protein</arg>
                </example>
                <example src="REPLACE" no="768">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="769">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="770">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="771">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="772">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="773">
                    <text>Previous studies using the encephalomiocarditis virus type alternate postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which will be genetically designed to truncate or replace the A1 sectors (poly(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="774">
                    <text>Previous studies using the encephalomiocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, noted that genetic engineering is capable of replacing or truncating the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="775">
                    <text>Previous studies using the encephalomiocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to replace or truncate the poly(C) sectors, produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="776">
                    <text>Previous studies using the encephalomiocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which are observed as genetic engineering to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the polio sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="777">
                    <text>Previous studies using the encephalomiocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which have been shown to replace or truncate the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="778">
                    <text>Previous studies using the encephalomiocarditis virus type alternated postsynaptic density 95 (PSD95) isoforms and Mengo virus, and variants of these viruses, which were genetically designed to truncate or replace the A1 sectors (poli(C)) produced conflicting data on the role of the poli(C) sector in the virulence of these viruses.</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="779">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, PVR is also liable to truncation before P motif.</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">P motif</arg>
                </example>
                <example src="REPLACE" no="780">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, PVR is also liable to truncation before PP-motif.</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-motif</arg>
                </example>
                <example src="REPLACE" no="781">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, PVR is also liable to truncation before PP-reason.</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">PP-reason</arg>
                </example>
                <example src="REPLACE" no="782">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, PVR is also liable to truncation before the PP reason.</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP reason</arg>
                </example>
                <example src="REPLACE" no="783">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, PVR is also liable to truncation before the PP-motif.</text>
                    <arg n="1">PVR</arg>
                    <arg n="3">the PP-motif</arg>
                </example>
                <example src="REPLACE" no="784">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Stat5a proteins truncated by C-terminal is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="785">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Stat5a proteins truncated by C-terminally is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Stat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="786">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Stat5a truncated proteins by C is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Stat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="787">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, State 5th C truncated proteins is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">State 5th C truncated proteins</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="788">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Strat5a proteins truncated by C-terminal is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminal</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="789">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Strat5a proteins truncated by C-terminally is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Strat5a proteins truncated by C-terminally</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="790">
                    <text>Thus, to truncated a soluble fragment comparable to IC1-2D/190, Strat5a truncated proteins by C is also liable to truncation before amino acids 762 or 773.</text>
                    <arg n="1">Strat5a truncated proteins by C</arg>
                    <arg n="3">amino acids 762 or 773</arg>
                </example>
                <example src="REPLACE" no="791">
                    <text>a genetic direction approach frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">a genetic direction approach</arg>
                </example>
                <example src="REPLACE" no="792">
                    <text>altered postsynaptic density 95 (PSD95) isoforms frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">altered postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="793">
                    <text>altered the post-synaptic density level 95 (PSD95) isoformes frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">altered the post-synaptic density level 95 (PSD95) isoformes</arg>
                </example>
                <example src="REPLACE" no="794">
                    <text>altered the postsynaptic density 95 (PSD95) isoforms frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">altered the postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="795">
                    <text>alternate postsynaptic density 95 (PSD95) isoforms frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">alternate postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
                <example src="REPLACE" no="796">
                    <text>alternated postsynaptic density 95 (PSD95) isoforms frame change, as our data show, A2 truncated (its two activation domains), while all remaining mutations reported so far are in the high-mobility group DNA binding domain (HMG).</text>
                    <arg n="0">alternated postsynaptic density 95 (PSD95) isoforms</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
